Ekaterina specialises in the legal regulation of the healthcare industry, including matters relating to: clinical trials of medicinal products (CSU), marketing (MR) and pharmacoeconomic studies, retrospective patient data research (RWE, RWD), regulation of intellectual property (IP) assets, and pharmaceutical product labelling (track & trace).
Selected Experience
Healthcare and Life Science
Ekaterina advised:
Finnish and American pharmaceutical companies – manufacturers of medicinal products – in disputes with distributors regarding delayed payment for goods;
a number of pharmaceutical manufacturers in the bankruptcy case of a pharmaceutical distributor;
the Russian subsidiary of a Japanese equipment supplier in cases related to fraudulent actions of its general director;
an individual in bankruptcy proceedings that resulted in the client being released from debts exceeding RUB 100 million;
a Canadian citizen in a dispute with the FSB of Russia challenging an entry ban to the Russian Federation;
a major Northern Irish bank in cases involving the protection of creditors’ rights and challenging unlawful actions of a former insolvency administrator;
an international car dealer in consumer disputes;
a Swedish pharmaceutical holding in a dispute with the Federal Customs Service of the Russian Federation;
one of the largest Belarusian banks in the recognition and enforcement in Russia of a Belarusian court judgment.